{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:15:25Z","timestamp":1779207325208,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabet.2026.101757","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:59:28Z","timestamp":1775181568000},"page":"101757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effectiveness of different advanced hybrid closed-loop systems on time in tight range in adults with type 1 diabetes: A multicenter real-world study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6099-6014","authenticated-orcid":false,"given":"Ignacio","family":"Gonzalez-Maroto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-1094","authenticated-orcid":false,"given":"Jesus","family":"Moreno-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-4969","authenticated-orcid":false,"given":"Pilar Isabel","family":"Beato-V\u00edbora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0423-6446","authenticated-orcid":false,"given":"Carmen","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2026.101757_bib0001","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.2337\/dc24-S007","article-title":"7. Diabetes technology: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1159\/000543034","article-title":"International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: diabetes technologies - insulin delivery","volume":"97","author":"Biester","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.diabet.2026.101757_bib0003","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabet.2026.101757_bib0004","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000543156","article-title":"International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024 diabetes technologies: glucose monitoring","volume":"97","author":"Tauschmann","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.diabet.2026.101757_bib0005","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","article-title":"New closed-loop insulin systems","volume":"64","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2026.101757_bib0006","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A systematic review of commercial hybrid closed-loop automated insulin delivery systems","volume":"14","author":"Peacock","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0007","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2026.101757_bib0009","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2026.101757_bib0010","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2026.101757_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the minimedtm 780g system: first report of outcomes from 4120 users","volume":"24","author":"Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/dia.2023.0453","article-title":"Early real-world performance of the minimedtm 780g advanced hybrid closed-loop system and recommended settings use in the united states","volume":"26","author":"Thrasher","year":"2024","journal-title":"Diab Technol Therap"},{"key":"10.1016\/j.diabet.2026.101757_bib0013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of control-IQ technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/19322968231185348","article-title":"Real-world evidence analysis of a hybrid closed-loop system","volume":"19","author":"Alwan","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabet.2026.101757_bib0015","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2026.101757_bib0016","first-page":"922","article-title":"Critical reappraisal of the time-in-range: alternative or useful addition to glycated hemoglobin?","volume":"1","author":"Heinemann","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabet.2026.101757_bib0017","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4093\/dmj.2020.0257","article-title":"Time in range from continuous glucose monitoring: a novel metric for glycemic control","volume":"44","author":"Yoo","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabet.2026.101757_bib0018","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0019","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-024-06171-y","article-title":"The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study","volume":"67","author":"De Meulemeester","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2026.101757_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110907","article-title":"Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systems","volume":"204","author":"Papa","year":"2023","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.diabet.2026.101757_bib0021","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc22-1692","article-title":"Simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed loop system: a randomized controlled trial comparing glucose control","volume":"46","author":"Petrovski","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0022","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc22-0470","article-title":"Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G Advanced hybrid closed-loop system: a two-center, randomized, controlled study","volume":"45","author":"Matejko","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0023","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2022.0558","article-title":"A meta-analysis of randomized trial outcomes for the t:slim X2 insulin pump with control-IQ technology in youth and adults from age 2 to 72","volume":"25","author":"Beck","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/endocrines6030034","article-title":"Time in tight range: a new frontier in glycemic control or just a tighter time in range? A narrative review","volume":"6","author":"Diaz Soto","year":"2025","journal-title":"Endocrines"},{"key":"10.1016\/j.diabet.2026.101757_bib0025","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0026","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/dom.16212","article-title":"Impact of time in tight range on all-cause and cardiovascular mortality in type 2 diabetes: a prospective cohort study","volume":"27","author":"Cai","year":"2025","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0027","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/dom.16143","article-title":"Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes","volume":"27","author":"Wang","year":"2025","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0028","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s13300-024-01656-w","article-title":"12-month time in tight range improvement with advanced hybrid-closed loop system in adults with type 1 diabetes","volume":"15","author":"Nigi","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0029","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1111\/dom.15766","article-title":"Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: a 1-year real-world assessment","volume":"26","author":"Rizzi","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0030","doi-asserted-by":"crossref","first-page":"e3826","DOI":"10.1002\/dmrr.3826","article-title":"Time In Tight Range in children and adolescents with type 1 diabetes: a cross-sectional observational single centre study evaluating efficacy of new advanced technologies","volume":"40","author":"Schiaffini","year":"2024","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.diabet.2026.101757_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15333","article-title":"Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: a single-centre real-world study","volume":"41","author":"Eviz","year":"2024","journal-title":"Diab Med"},{"key":"10.1016\/j.diabet.2026.101757_bib0032","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12020-024-03881-6","article-title":"Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems","volume":"86","author":"Bahillo-Curieses","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.diabet.2026.101757_bib0033","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/dc23-2311","article-title":"Sustained effectiveness of an advanced hybrid closed-loop system in a cohort of children and adolescents with type 1 diabetes: a 1-year real-world study","volume":"47","author":"Passanisi","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0034","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/pedi.12817","article-title":"Translating glycated hemoglobin A1c into time spent in glucose target range: a multicenter study","volume":"20","author":"Petersson","year":"2019","journal-title":"Pediatric Diab"},{"issue":"5","key":"10.1016\/j.diabet.2026.101757_bib0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00592-024-02397-9","article-title":"Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems","volume":"62","author":"Borella","year":"2025","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabet.2026.101757_bib0036","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","article-title":"Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms","volume":"18","author":"Clarke","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0037","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2337\/dc06-2556","article-title":"An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes","volume":"30","author":"Geddes","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2026.101757_bib0039","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/diacare.10.5.617","article-title":"Fear of hypoglycemia: quantification, validation, and utilization","volume":"10","author":"Cox","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.endinu.2017.12.003","article-title":"Spanish translation, adaptation and validation of the Hypoglycemia fear survey in adults with type 1 diabetes in the community of Madrid","volume":"65","author":"Tasende","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"6","key":"10.1016\/j.diabet.2026.101757_bib0041","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2165\/00019053-199610060-00007","article-title":"Evaluation of the diabetes quality-of-life questionnaire in a Spanish population","volume":"10","author":"Reviriego","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.diabet.2026.101757_bib0042","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1575-0922(02)74482-3","article-title":"Revaluaci\u00f3n de la versi\u00f3n espa\u00f1ola del cuestionario Diabetes Quality of Life (EsDQOL)","volume":"49","author":"Mill\u00e1n","year":"2002","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.diabet.2026.101757_bib0043","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/diabetology6070069","article-title":"Time in tight range in AHCL Systems: propensity-score-matched analysis of MiniMed 780G and Control-IQ","volume":"6","author":"Sanchiz","year":"2025","journal-title":"Diabetology"},{"key":"10.1016\/j.diabet.2026.101757_bib0044","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1111\/dom.15791","article-title":"Time in tight range in automated insulin delivery system users: real-world data from children and adolescents with type 1 diabetes","volume":"26","author":"Piona","year":"2024","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc23-1581","article-title":"Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system","volume":"47","author":"Casta\u00f1eda","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109784","article-title":"Switching from predictive low glucose suspend to advanced hybrid closed loop control: effects on glucose control and patient reported outcomes","volume":"185","author":"Boscari","year":"2022","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.diabet.2026.101757_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102852","article-title":"Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes: a systematic review and meta-analysis","volume":"76","author":"Roos","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.diabet.2026.101757_bib0048","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.3390\/s23229256","article-title":"Factory-calibrated continuous glucose monitoring systems in type 1 diabetes: accuracy during in-clinic exercise and home use","volume":"23","author":"Lundemose","year":"2023","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.diabet.2026.101757_bib0049","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2026.101757_bib0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2337\/dci23-0092","article-title":"Time in tight range for patients with type 1 diabetes: the time is now, or is it too soon?","volume":"47","author":"Hamidi","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101757_bib0051","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/dom.14807","article-title":"Predictors of time in target glucose range in real-world users of the MiniMed 780G system","volume":"24","author":"Casta\u00f1eda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabet.2026.101757_bib0052","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/dia.2023.0373","article-title":"Aiming for the best glycemic control beyond time in range: time in tight range as a new continuous glucose monitoring metric in children and adolescents with type 1 diabetes using different treatment modalities","volume":"26","author":"Passanisi","year":"2024","journal-title":"Diab Technol Therap"},{"key":"10.1016\/j.diabet.2026.101757_bib0053","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/1932296819826965","article-title":"Performance and usability of three systems for continuous glucose monitoring in direct comparison","volume":"13","author":"Freckmann","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabet.2026.101757_bib0054","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc25-0129","article-title":"A comparative analysis of glycemic metrics derived from three continuous glucose monitoring systems","volume":"48","author":"Freckmann","year":"2025","journal-title":"Diabetes Care"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:56:18Z","timestamp":1779206178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363626000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1262363626000364"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101757","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical effectiveness of different advanced hybrid closed-loop systems on time in tight range in adults with type 1 diabetes: A multicenter real-world study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101757"}}